A Personalized Prehabilitation Intervention In Elective Joint Replacement Surgery
Primary Purpose
Arthropathy of Knee Joint, Arthropathy of Hip Joint
Status
Suspended
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
personalized prehabilitation
Sponsored by
About this trial
This is an interventional prevention trial for Arthropathy of Knee Joint focused on measuring elective
Eligibility Criteria
Inclusion Criteria:
- Adults scheduled for elective arthroplasty;
- ≥55 years of age;
- Capable of giving informed consent;
- Willing to comply either to undergo prehabilitation (cases) or standard preoperative care (control);
- Own a smartphone.
Exclusion Criteria:
- Patients with bilateral or revision surgeries;
- Diagnosis of pre-existing dementia;
- Test result of <20 in the MoCA indicating moderate to severe dementia;
- Diagnosis of acute stroke;
- Diagnosis of neurologic injury;
- Current alcohol (more than 2 drinks a day with last drink within the past 3 days) or substance abuse (positive urine dip test for illicit drugs) history at risk of postoperative withdrawal;
- Active diagnosis of alcohol or substance abuse;
- Recent travel across more than two (2) time zones (within the past month);
- Planned travel across more than two (2) time zones during the planned study activities;
- Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening;
- Subjects without access to WiFi in their or close to home or at work.
Sites / Locations
- University of Pennsylvania School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Enhanced Monitoring Program
Regular Monitoring Program
Arm Description
Four weeks prior to the scheduled (elective) surgery, participants will receive a 60-minute in person education session how to increase the level of physical activity. This will be followed by 4 weeks of keeping this level of physical activity, which will be monitored and supported by personalized interactive prompts delivered by a smartwatch. This approach is called personalized prehabilitation.
Participants randomized to this arm will receive standard perioperative care.
Outcomes
Primary Outcome Measures
Change from baseline, pre-prehabilitation cognitive function at 30±2 days post-operative
Difference in cognitive function as assessed by the CogState Brief Battery for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Secondary Outcome Measures
Change from baseline, pre-prehabilitation physical activity [vector magnitude] at 30±2 days post-operative
Difference in physical activity for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Change from baseline, pre-prehabilitation step count [number] at 30±2 days post-operative
Difference in step count for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Change from baseline, pre-prehabilitation sleep duration [hours] at 30±2 days post-operative Difference in sleep parameters
Difference in sleep duration for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Change from baseline, pre-prehabilitation circadian phase [hours] of activity
Difference in circadian phase for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Change from baseline, pre-prehabilitation circadian amplitude [difference between the maximum and minimum observed values] of activity
Difference in circadian phase for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Compliance
Compliance to the four-week prehabilitation paradigm assessed as the delta between the first and fourth (last) week of physical activity in the intervention group
Difference in incidence of delirium
Difference in incidence of delirium between Intervention vs. Control assessed from patient charts at 'post-operative day 30±2'
Difference in concentrations of Interleukin-6 (IL-6) [pg/mL]
Difference in concentrations between Intervention vs. Control
Difference in concentrations of S100β [ng/mL]
Difference in concentrations between Intervention vs. Control
Difference in hospital length of stay
Difference in hospital length of stay [days] for Intervention vs. Control
Full Information
NCT ID
NCT03601728
First Posted
May 3, 2018
Last Updated
September 7, 2023
Sponsor
University of Pennsylvania
1. Study Identification
Unique Protocol Identification Number
NCT03601728
Brief Title
A Personalized Prehabilitation Intervention In Elective Joint Replacement Surgery
Official Title
A Personalized Medicine Prehabilitation Intervention Delivered Using Wearable Mobile Devices to Improve Cognitive Function in Elective Joint Replacement Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Suspended
Why Stopped
Covid-19 Crisis
Study Start Date
October 1, 2019 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The mission is to develop novel interventions to improve cognitive function, and thereby reducing delirium in hospitalized patients to improve perioperative outcomes. Delirium affects up to 42% of hospitalized patients and disproportionately increases morbidity and mortality in older adults, especially after surgical procedures. Current approaches prevent only 30-40% of delirium cases. The goal is to use prehabilitation (an individualized exercise regimen performed in the 2-4 weeks prior to admission) to improve peri-operative cognitive status, mobility and recovery. Based on preliminary data, the investigators propose to deeply phenotype patients, meaning to study the patient, the disease and surgery in a very detailed fashion, with elective knee or hip replacement surgery and use a personalized prehabilitation intervention compared to standard pre-operative care. To facilitate data collection over the course of the study, the investigators use wearable devices and mobile phone applications.
Detailed Description
The fiscal burden estimated at $164 billion annually in the US alone, with delirium often leading to significant increases in hospital length of stay. The pathophysiology of delirium is multifactorial and incompletely understood. Disruption of circadian rhythms, with subsequent impairment of alertness, and increased inflammation including neuroinflammation, is common in hospital environments, and is associated with poorer outcome, particularly in the elderly.
An intriguing new therapeutic concept currently emerging in the area of elective surgery is prehabilitation, a form of exercise training, which when pre-emptively administered in the weeks prior to admission, has the potential to improve postoperative cognitive status, mobility and recovery, thereby minimizing complications such as delirium. Our team has recently developed a novel personalized medicine intervention that uses wearable devices (smartwatches) to create an individualized exercise regimen for older adults that can facilitate prehabilitation and monitor adherence to the prehabilitation regimen while the patient is at home. In one sense, prehabilitation can be conceptualized as bouts of physical exercise performed at home prior to admission, which, when adequately timed using guidance by a wrist-worn biometric mobile device (smartwatch), augment the robustness of circadian rhythms, particularly in the elderly. This intervention has the potential to have a high impact because of its low cost, personalized nature, and ability to monitor adherence to confirm maximization of functional status prior to admission.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthropathy of Knee Joint, Arthropathy of Hip Joint
Keywords
elective
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Matched case-control study design
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Enhanced Monitoring Program
Arm Type
Experimental
Arm Description
Four weeks prior to the scheduled (elective) surgery, participants will receive a 60-minute in person education session how to increase the level of physical activity. This will be followed by 4 weeks of keeping this level of physical activity, which will be monitored and supported by personalized interactive prompts delivered by a smartwatch. This approach is called personalized prehabilitation.
Arm Title
Regular Monitoring Program
Arm Type
No Intervention
Arm Description
Participants randomized to this arm will receive standard perioperative care.
Intervention Type
Behavioral
Intervention Name(s)
personalized prehabilitation
Other Intervention Name(s)
Enhanced Monitoring Program
Intervention Description
The 60-minute education session includes a 30-minute general education on exercise in older adults and a 30-minute instruction on participating in the study intervention (how to work with the personalized circadian-based activity guideline). The education session will be developed and presented by the PI and the certified exercise trainer. The general education session will be designed using materials from Go4Life program from the National Institute on Aging (https://go4life.nia.nig.gov). The personalized circadian-based activity guideline (exercise goal and plan) will be developed by the investigators and the exercise trainer based on the individual's typical daily circadian profile, functional status, preference for exercise.
Primary Outcome Measure Information:
Title
Change from baseline, pre-prehabilitation cognitive function at 30±2 days post-operative
Description
Difference in cognitive function as assessed by the CogState Brief Battery for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Time Frame
30±2 days post-operative
Secondary Outcome Measure Information:
Title
Change from baseline, pre-prehabilitation physical activity [vector magnitude] at 30±2 days post-operative
Description
Difference in physical activity for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Change from baseline, pre-prehabilitation step count [number] at 30±2 days post-operative
Description
Difference in step count for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Change from baseline, pre-prehabilitation sleep duration [hours] at 30±2 days post-operative Difference in sleep parameters
Description
Difference in sleep duration for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Change from baseline, pre-prehabilitation circadian phase [hours] of activity
Description
Difference in circadian phase for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Change from baseline, pre-prehabilitation circadian amplitude [difference between the maximum and minimum observed values] of activity
Description
Difference in circadian phase for the condition 'baseline, pre-prehabilitation' versus 30±2 days post-operative between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Compliance
Description
Compliance to the four-week prehabilitation paradigm assessed as the delta between the first and fourth (last) week of physical activity in the intervention group
Time Frame
2 months
Title
Difference in incidence of delirium
Description
Difference in incidence of delirium between Intervention vs. Control assessed from patient charts at 'post-operative day 30±2'
Time Frame
30±2 days post-operative
Title
Difference in concentrations of Interleukin-6 (IL-6) [pg/mL]
Description
Difference in concentrations between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Difference in concentrations of S100β [ng/mL]
Description
Difference in concentrations between Intervention vs. Control
Time Frame
30±2 days post-operative
Title
Difference in hospital length of stay
Description
Difference in hospital length of stay [days] for Intervention vs. Control
Time Frame
30±2 days post-operative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults scheduled for elective arthroplasty;
≥55 years of age;
Capable of giving informed consent;
Willing to comply either to undergo prehabilitation (cases) or standard preoperative care (control);
Own a smartphone.
Exclusion Criteria:
Patients with bilateral or revision surgeries;
Diagnosis of pre-existing dementia;
Test result of <20 in the MoCA indicating moderate to severe dementia;
Diagnosis of acute stroke;
Diagnosis of neurologic injury;
Current alcohol (more than 2 drinks a day with last drink within the past 3 days) or substance abuse (positive urine dip test for illicit drugs) history at risk of postoperative withdrawal;
Active diagnosis of alcohol or substance abuse;
Recent travel across more than two (2) time zones (within the past month);
Planned travel across more than two (2) time zones during the planned study activities;
Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening;
Subjects without access to WiFi in their or close to home or at work.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carsten Skarke, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania School of Medicine
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
to be determined
Citations:
PubMed Identifier
29215023
Citation
Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, Weljie AM, FitzGerald GA. A Pilot Characterization of the Human Chronobiome. Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6.
Results Reference
background
Links:
URL
https://lp.pennmedicine.org/precision-medicine/general?hcmacid=pm
Description
Study support by the Penn Center for Precision Medicine (PCPM)
URL
https://www.youtube.com/watch?v=XpEu03PQM0Q
Description
Study description in a 1-minute YouTube video
Learn more about this trial
A Personalized Prehabilitation Intervention In Elective Joint Replacement Surgery
We'll reach out to this number within 24 hrs